Indian Air Force (IAF) group captain Shubanshu Shukla, who is ready to make history as the first Indian astronaut to travel to the International Space Station (ISS) this year, will probably conduct at least three experiments, including research on the loss of muscle in space.
Minister of State (MOS) for Science and Technology, Dr. Jitendra Singh said that Mr. Shukla will focus on “Space Technology, Space Bio-Manufacturing and Bio-Astronautics” during the latter fortnight-lamb space mission. The IAF officer will develop special micro -organisms in football -shaped space station to search for food algae; Develop special bacteria; And study effects on muscle cells, and understand why astronauts face muscle loss in space.
Medical experts have expressed concern over the health and muscle atrophy of Indian original-internal passenger Sunita Williams, who have recently returned to Earth after nine months of horrific migration at ISS.
Dr. Singh said, “Space is an unforgivable environment and becoming just an astronaut does not change the basic human physiology.”
He said that continuous availability of nutrients, conservation of food, microorganisms, radiation, physical changes and health hazards in astronauts, potable water and a way of cleaning and using waste in a permanent way are some major challenges in space, he said. “It is estimated that by 2050, commercial space travel is going to be a reality and we need to be ready for the future. By this end, the Department of Biotechnology (DBT) and the Indian Space Research Organization (ISRO) will jointly handle mission projects, focus on simple space bio-manufacturing experiments,” he said.
According to the National Aeronautics and Space Administration (NASA), Mr. Shukla, a private astronaut mission, who will use a private astronaut mission in a spacexx dragon spacecraft. The American Space Agency is expected to start the mission from the Kennedy Space Center in Florida, possibly in early May. The crew will conduct an outreach program and commercial activities in microgravity as part of a collaboration between NASA and ISRO.
The third experiment will focus on the adverse effects of astronauts on the physiology of astronauts. (DBT)
Mr. Singh said that the subtle gravitational environment will offer unique challenges. Indian experiment, however, will assist the upcoming Gaganan and Indian Anticsh Station programs, he said.
Providing the details, MOS said that the first experiment would include using some food micro -classes to develop them in space and to see if they are found flexible in space conditions and can act as a permanent source of foods like protein, carbohydrates, lipids and vitamins A, B1, B1, B6, B12, C and E. These algae will be grown in enclosed containers and fed with water and carbon dioxide, saying that this experiment will be done by the International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi.
The second experiment led by ICGEB will aim to create waste-to-ride in space. The urea present in the urine of astronauts will be used to grow some blue-green algae called Spirulina and a desert species called Cherococycidiopsis, called ministers. Resource recycling is important in space as the halling material is extremely expensive.
Mr. Singh says that the third experiment will be done by the Institute for Stem Sale Science and Regimental Medicine, Bangalore, and will focus on the adverse effects of space conditions on astronauts on physiology, and how to reduce them.
Reports suggest that astronauts experience 20% muscle loss in space flights lasting five to 11 days. On the other hand, it takes decades for muscle loss or sarcopenia to develop on Earth. By using supplements in a muscle cell culture model, researchers are trying to increase the mitochondrial function, which is an important component in this situation. On Earth, this experiment is expected to help patients to face the same muscle loss.
India’s bio -economic system has experienced a significant increase – in 2014 to $ 10 billion to $ 151 billion in 2023, with estimates with estimates to reach $ 300 billion by 2030.
In a statement, DBT stated that cooperation with ISRO would pursue space biotechnology research in India and would contribute significantly to our country’s space economy. The space economy is expected to grow five times in the next 10 years, up to $ 44 billion.
One of the niche regions is a space bio-manufacturing, which has a professional capacity like “prosthesis growth”, which requires scaffolding on Earth to keep tissue layers together. When used in space, tissue layers are not separated and scaffolding is not required. DBT and ISRO will also see the future goal of prostheses development, in orgenoids development in space.
It can be noted that three very simple experiments were carried out on an ISRO module called Kavita earlier this year to develop the set of lobby seeds, bacteria and spinach cells in space. These were the first experiments related to biology conducted by Indians in the microgravity of space.
